개인구독
소속 기관이 없으신 경우, 개인 정기구독을 하시면 저렴하게
논문을 무제한 열람 이용할 수 있어요.
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
이 논문의 연구 히스토리 (2)
2016
- 이 논문의 후속연구가 궁금하신가요?
- 연관 학술논문 또는 학술발표를 통해 보다 발전된 연구결과를 확인하실 수 있습니다.
- 이 논문의 연구 히스토리 확인하기
초록· 키워드
오류제보하기
Objective: Prescription rate of dabigatran and rivaroxaban, which are the direct oral anticoagulants (DOAC), has increased. We have analyzed the prescription trend and medication use of dabigatran and rivaroxaban in patients with non-valvular atrial fibrillation (NVAF). Methods: It was retrospectively studied from September 2012 to April 2014 using the electronic medical records and the progress notes. Patients with NVAF (n=424) were evaluated on the medication use, prescribing preferences, adverse drug reactions (ADRs) and the availability of prescription reimbursement of dabigatran (n=210) and rivaroxaban (n=214). Results: Dabigatran was prescribed higher than rivaroxaban (23.3% versus 7.5%, p<0.001) in the neurology department, but rivaroxaban was prescribed higher compared to dabigatran in the cardiology department (87.4% versus 74.3%, p<0.001). Dabigatran was prescribed more than rivaroxaban in high risk patients with CHADS2 score ≥ 3 (44.3% versus 31.3%, p=0.006). Dabigatran patients seemed to have more ADRs than patients with rivaroxaban (25.2% versus 11.2%, p<0.001), but no serious thrombotic events and bleeding were found. Only 35.6% (n=151) were eligible for prescription reimbursement by the National Health Insurance (NHI). Bridging therapy (86, 31.5%) and direct-current cardioversion (57, 20.2%) were main reasons of ineligibility for reimbursement. Conclusion: Prescription preferences were present in choosing either dabigatran or rivaroxaban for patients with NVAF. Inpatient protocols and procedures considering patient-factors in NVAF need to be developed.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
비판막성심방세동 환자에서 직접작용 경구용 항응고제 임상적 효과와 부작용 연구
한국임상약학회지
2022 .03
-
Hemopericardium and cardiac tamponade in a patient treated with dabigatran etexilate
Korean Circulation Journal
2016 .01
-
Dabigatran Effect on Left Ventricular Thrombus in a Patient with Acute Ischemic Stroke
대한뇌졸중학회지
2015 .01
-
Recurrent and Drastic Increase in Dabigatran Levels May Be Induced by Therapeutic Plasma Exchange
대한뇌졸중학회지
2020 .01
-
Te Need for a Coagulation Assay afer Initiation of New Oral Anticoagulants in Patients with Renal Dysfunction: A Case Report
Journal of Clinical Neurology
2015 .01
-
Updates on Prevention of Cardioembolic Strokes
대한뇌졸중학회지
2018 .01
-
전극도자절제술을 시행 받는 심방세동 환자에서 Warfarin 대비 Dabigatran의 연속 사용에 관한 연구
International Journal of Arrhythmia
2017 .09
-
2018 대한부정맥학회 비판막성 심방세동 환자의 동율동 조절 약제 지침
대한내과학회지
2018 .01
-
Effects of Long-term Thrombin Inhibition (Dabigatran Etexilate) on Spontaneous Thrombolytic Activity during the Progression of Atherosclerosis in ApoE−/−–LDLR−/− Double-Knockout Mice
Korean Circulation Journal
2020 .01
-
A Network Meta-Analysis Comparing Osteoporotic Fracture among Different Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Atrial Fibrillation
대한골대사학회지
2021 .01
-
Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation: A Pilot Randomized Trial
대한뇌졸중학회지
2023 .05
-
Is Lighter Intensity of Warfarin Therapy Enough for Korean Patients with Non-Valvular Atrial Fibrillation?
Korean Circulation Journal
2020 .01
-
Quality of Anticoagulation and Treatment Satisfaction in Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonist: Result from the KORean Atrial Fibrillation Investigation II
Journal of Korean Medical Science
2018 .01
-
Association Between Plasma Anti-Factor Xa Concentrations and Large Artery Occlusion in Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants for Non-valvular Atrial Fibrillation
Annals of Laboratory Medicine
2024 .09
-
심방세동의 비약물적 치료
International Journal of Arrhythmia
2017 .09
-
Cardiovascular Biomarkers during Acute Periods of Ischemic Stroke due to Non-Valvular Atrial Fibrillation
Journal of Neurocritical Care
2018 .01
-
Perioperative outcomes of interrupted anticoagulation in patients with non-valvular atrial fibrillation undergoing non-cardiac surgery
Journal of Yeungnam Medical Science
2020 .01
-
Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for Stroke
대한뇌졸중학회지
2015 .01
-
The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation
대한뇌졸중학회지
2016 .01
-
비판막성 심방세동 환자에서 CHA2DS2-VASc 점수와 좌심방 확장 및 D-dimer의 연관성
Journal of Neurocritical Care
2016 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0